用户验证的应用
经验证应用
| 项目 | 详情 |
|---|---|
| WB | 1:1000-1:5000 |
| ELISA | 1:5000-1:10000 |
应用说明
IHC, FCM, IF, IP et al. applications haven't been validated. (Antibody's applications haven't been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)
推荐稀释说明
Optimal concentrations/dilutions should be determined by the end user.
详细信息
特异性
SARS-CoV Nucleocapsid Has cross-reactivity in ELISA and WB with SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein (Cat# 40588-V08B).
制备方法
Produced in rabbits immunized with purified, recombinant SARS-CoV Nucleocapsid (Catalog#40143-V08B; NP_828858.1; Met1-Ala422). SARS-CoV Nucleocapsid specific IgG was purified by SARS-CoV Nucleocapsid affinity chromatography.
运输条件
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
背景信息
Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein. The coronavirus N protein is required for coronavirus RNA synthesis and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is the most abundant protein of coronavirus. During virion assembly, N protein binds to viral RNA and leads to the formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. Because of the conservation of the N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool. References 1.Van Boheemen S, et al. (2012), MBio. 3(6):e00473-12. Bisht H. et al., 2004, Proc Natl Acad Sci. 101 (17): 6641-6. Li W. et al., 2005, Science. 309 (5742): 1864-8.
文献引用 (83)
A novel, covalent broad-spectrum inhibitor targeting human coronavirus M(pro).
一种新型的、针对人类冠状病毒 M(pro) 的共价广谱抑制剂
Investigating post-infection anxiety- and depression-like behaviors in a SARS-CoV-2 mouse model.
利用 SARS-CoV-2 小鼠模型研究感染后焦虑和抑郁样行为
Sequential intranasal booster triggers class switching from intramuscularly primed IgG to mucosal IgA against SARS-CoV-2
连续鼻腔内加强注射可触发从肌肉注射引发的 IgG 到针对 SARS-CoV-2 的粘膜 IgA 的类别转换
Intranasal recombinant protein subunit vaccine targeting TLR3 induces respiratory tract IgA and CD8 T cell responses and protects against respiratory virus infection
鼻内重组蛋白亚单位疫苗靶向TLR3,可诱导呼吸道IgA和CD8 T细胞反应,并预防呼吸道病毒感染。
SARS-CoV-2 Productively Infects Human Hepatocytes and Induces Cell Death
SARS-CoV-2 有效感染人类肝细胞并诱导细胞死亡
Adenovirus Nanoparticles Displaying RBD Induce a Protective Immune Response Against BA.5 in Mice
表达RBD的腺病毒纳米颗粒可诱导小鼠产生针对BA.5的保护性免疫反应
Complement is primarily activated in the lung in a mouse model of severe COVID-19
在严重 COVID-19 小鼠模型中,补体主要在肺中被激活
Dominant and cross-reactive S1-specific memory B cell response induced by primary SARS-CoV-2 infection.
由原发性SARS-CoV-2感染诱导的优势和交叉反应性S1特异性记忆B细胞反应
Thymic stromal lymphopoietin improves protective immunity of the SARS-CoV-2 subunit vaccine by inducing dendritic cell-dependent germinal center response.
胸腺基质淋巴细胞生成素通过诱导树突状细胞依赖性生发中心反应来提高 SARS-CoV-2 亚单位疫苗的保护性免疫力
Neuroinvasive and neurovirulent potential of SARS-CoV-2 in the acute and post-acute phase of intranasally inoculated ferrets.
SARS-CoV-2 在鼻内接种雪貂的急性期和急性后期阶段的神经侵袭性和神经毒性潜力
- 1
- 2
- 3
- 4
- 5
- 6
- 9